Literature DB >> 6306721

Hepatic artery embolization in 120 patients with unresectable hepatoma.

R Yamada, M Sato, M Kawabata, H Nakatsuka, K Nakamura, S Takashima.   

Abstract

Transcatheter hepatic artery embolization was performed in 120 patients with unresectable hepatoma. The cumulative one-year survival rate was 44%. In most cases follow-up angiography revealed the selective disappearance of tumor vessels, and computed tomography demonstrated a marked decrease in tumor density without any changes in the surrounding liver parenchyma. Histologic examination in 14 cases confirmed these findings.

Entities:  

Mesh:

Year:  1983        PMID: 6306721     DOI: 10.1148/radiology.148.2.6306721

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  230 in total

1.  Flow cytometric analysis of the nuclear DNA content of hepatocellular carcinoma.

Authors:  H Ishizu
Journal:  Jpn J Surg       Date:  1989-11

2.  Analysis of prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization.

Authors:  K Yamamoto; M Masuzawa; M Kato; T Okuyama; K Tamura
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

3.  Hepatocellular carcinoma.

Authors:  T Ezaki
Journal:  BMJ       Date:  1992-01-25

4.  Re: Transcatheter hepatic artery embolization of hepatomas and coexisting portal flow restriction.

Authors:  P G Tarazov
Journal:  Cardiovasc Intervent Radiol       Date:  1992 Mar-Apr       Impact factor: 2.740

5.  Comparison of local control effects of superselective transcatheter arterial chemoembolization using epirubicin plus mitomycin C and miriplatin for hepatocellular carcinoma.

Authors:  Shiro Miyayama; Masashi Yamashiro; Yoshihiro Shibata; Masahiro Hashimoto; Miki Yoshida; Kazunobu Tsuji; Fumihito Toshima; Osamu Matsui
Journal:  Jpn J Radiol       Date:  2012-01-07       Impact factor: 2.374

6.  A prospective randomized controlled trial of preoperative whole-liver chemolipiodolization for hepatocellular carcinoma.

Authors:  Masaki Kaibori; Noboru Tanigawa; Shuji Kariya; Hiroki Ikeda; Yoshitsugu Nakahashi; Junko Hirohara; Chizu Koreeda; Toshihito Seki; Satoshi Sawada; Kazuichi Okazaki; A-Hon Kwon
Journal:  Dig Dis Sci       Date:  2012-01-24       Impact factor: 3.199

7.  Effect of interval between transcatheter hepatic arterial embolization and radiofrequency ablation on ablated lesion size in a swine model.

Authors:  Cao Guang; Nobuyuki Kawai; Morio Sato; Isao Takasaka; Hiroki Minamiguchi; Shinya Sahara; Kouhei Nakata; Tetsuo Sonomura; Shintaro Shirai; Ichiro Mori; Renjie Yang
Journal:  Jpn J Radiol       Date:  2011-09-29       Impact factor: 2.374

8.  Transcatheter arterial chemoembolization with anticancer drug in iodized oil for primary hepatic carcinoma.

Authors:  J Y Guo; D Yen; Z Z Huang; G D Hu; P C Liu
Journal:  Cardiovasc Intervent Radiol       Date:  1989 Jul-Aug       Impact factor: 2.740

9.  Implications of hyperechoic lesions in small hepatocellular carcinoma.

Authors:  T Kanno; N Kurioka; S Kim; A Tamori; K Kim; H Oka; T Kuroki; Y Mizoguchi; K Kobayashi
Journal:  Gastroenterol Jpn       Date:  1989-10

10.  The effects of hepatic artery chemotherapy on viral hepatitis in patients with hepatocellular carcinoma.

Authors:  Jawad Ahmad; John Rhee; Brian I Carr
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.